Clinical Trial Update: Talazoparib Maintenance Therapy in Triple-negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for talazoparib maintenance therapy in triple-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Talazoparib (talazoparib)

Snippet

Sponsor: Yonsei University | Conditions: TNBC - Triple-Negative Breast Cancer | Phase 2 | Status: UNKNOWN